News
Media
PodcastsCase Based Peer PerspectivesInsightsInvestigator PerspectivesMedical World NewsPeer ExchangePeers & PerspectivesVideos
Conferences
Conference CoverageConference Listing
Publications
Contemporary OB/GYN® JournalDigital Supplements
More
CME/CE
Resources
Physician Fact SheetsInteractive ToolsSponsored MediaSponsored ResourcesSupplements and Featured Publications
About
Partnerships

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • About
  • Partnerships
  • Breast Health
  • COVID-19
  • Cervical Health
  • Contraception
  • Curbside Consults
  • Dermatology
  • Drug Pipeline News
  • Endometriosis
  • Genetic Testing
  • Gynecology
    • Gynecologic Oncology
  • Imaging
    • Fetal Imaging
    • Abnormal Obstetrical Ultrasound
    • MRI
    • Ultrasound
    • Women's Imaging
    • Breast Imaging
    • Women's Ultrasound
  • Infertility
  • LARC
  • Legally Speaking
  • Life Transitions
  • Malpractice
  • Menopause
  • Mental Health
  • Noninvasive Prenatal Testing
  • Obstetrics
  • Opinion
  • Osteoporosis
  • Pediatrics
  • Practice Management
  • Pregnancy and Birth
  • Sexual Health
  • Sexually Transmitted Infections
  • Surgery
  • Technology
  • Urology
  • Uterine Fibroids
  • Vulvovaginal Disease
  • Well Woman
Advertisement

Susan M. Gapstur, PhD, MPH

Advertisement

Articles by Susan M. Gapstur, PhD, MPH

Hormone Replacement Therapy and Risk of Breast Cancer With a Favorable Histology

BySusan M. Gapstur, PhD, MPH,Monica Morrow, MD,Thomas A. Sellers, PhD,Susan M. Gapstur, PhD, MPH,Monica Morrow, MD,Thomas A. Sellers, PhD,Susan M. Gapstur, PhD, MPH,Monica Morrow, MD,Thomas A. Sellers, PhD
August 2nd 2011

To review, the recent article in the Lancet that he discussed showed that there was a very small increased risk of breast cancer by taking hormones over a prolonged length of time. However, certainly this risk should be viewed in the overall context of risks and benefits.

Advertisement

Latest Updated Articles

  • Hormone Replacement Therapy and Risk of Breast Cancer With a Favorable Histology
    Hormone Replacement Therapy and Risk of Breast Cancer With a Favorable Histology

    Published: August 2nd 2011 | Updated:



Advertisement
Advertisement

Trending on Contemporary OB/GYN

1

DARE to PLAY sildenafil cream becomes commercially available for women in select states

2

George L. Maxwell, MD, discusses phase 3 SUNFLOWER trial to evaluate Mirena for nonatypical endometrial hyperplasia

3

FDA approves zoliflodacin (Nuzolvence) for uncomplicated gonorrhea

4

Edward Hook, MD, discusses FDA approval of oral zoliflodacin for uncomplicated gonorrhea

5

Contemporary OB/GYN week in review: HPV vaccine, postpartum depression, and more

  • Advertise
  • Contact Us
  • Job Board
  • Terms of Use
  • Privacy Policy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us